SynthesisBMC public health2025
Worldwide prevalence of protozoans and helminths among disabled people: a systematic review and meta-analysis.
Synthesis in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundParasitic diseases represent a substantial public health concern on a global scale, particularly affecting communities characterized by low socioeconomic status and insufficient sanitation practices. Within these communities, individuals with disabilities are disproportionately impacted. According to the existing literature, it is posited that the prevalence of parasitic infections among disabled individuals is notably high, a factor often neglected when examining the intestinal parasites present in these individuals, alongside the diverse geographical and socioeconomic variations worldwide. This study posits that the prevalence of parasitic infections in individuals with disabilities is indeed elevated, and that there are significant socioeconomic and geographic disparities in species-specific prevalence. This study aimed to ascertain the global pooled prevalence of helminth and protozoan infections in individuals with disabilities, identify the prevalent parasite species, and compare the prevalence across various geographic regions worldwide.
methodsA systematic review and meta-analysis were conducted using the Reporting System for Systematic Reviews and Meta-Analyses. PubMed, Web of Science, Scopus, and the TR index were searched in August 2024 using the predetermined keywords. No time restrictions were imposed. The methodological quality of the studies was evaluated using the Joanna Briggs Institute's Critical Appraisal Checklist for randomized controlled, experimental, and cross-sectional studies. A meta-analysis method was used to pooled the data.
resultsA total of 12608 samples from 50 articles were included in the analysis. The pooled helminth and protozoan parasite prevalence was 40%, with high heterogeneity (I
conclusionThe global prevalence of protozoa and helminths among individuals with disabilities is significantly high, with notable occurrences in Canada, Philippines, and Ethiopia. The primary determinants of this situation include socioeconomic conditions, educational level, and geographical factors. It is imperative to educate disabled individuals and their families about transmission pathways and preventive measures for protozoa and helminths. Furthermore, local governments and public authorities should endeavor to improve the living conditions of individuals with disabilities, particularly those facing self-care challenges.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.